Novel microRNA-based Assay Demonstrates 92% Agreement With Diagnosis Based on Clinicopathologic and Management Data in a Cohort of Patients With Carcinoma of Unknown Primary
Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-12-57
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC